Lund University Cancer Centre – Clinical Trials and Diagnostics Meeting – Save the date

Dear all of LUCC, SUHCCC, and the local cancer-related life science community:

We welcome you to the second meeting of the new LUCC network, LUCC Clinical Trials and Diagnostics, devoted to sharing expertise and experiences in running clinical trials and connected translational biomarker studies:

LUCC – Clinical Trials and Diagnostics Meeting

Day: 4 March 2026

Time: 13:00 – 16:00

Location: Medicon Village – Inspira – room Allvar

Agenda & Speakers

Anyone working within cancer and clinical trials and diagnostics is welcome, including industry.

• Welcome (Lao Saal, Mats Jerkeman)
• Speakers

-Johannes Bobjer (SUS/LU) – PiCTURE urological cancer trial

-Göran Jönsson (LU) – SWE-NEO melanoma trial

-Maria Planck (SUS/LU) – ERIS lung cancer trial

-Läkemedelsverket – SweTrial – a new national initiative to strengthen clinical trials

-Anders Edsjö (SUS/LU) – FOCU.SE pan-cancer trial

-Emma Leire (Asgard Therapeutics AB) – Cellular reprogramming in cancer immunotherapy

• Discussion of future LUCC-CTaD activities
• Lots of time for discussions.

Please register to help us plan fika and coffee/tea accordingly.

Lao Saal, Associate Professor in Translational Oncogenomics at Lund University, Sweden &

Mats Jerkeman, Professor in Clinical Oncology at Lund University, Sweden, and Senior Consultant at Skåne University Hospital, Lund, Sweden